Development and psychometric evaluation of the epilepsy lifestyle questionnaire.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2024
Historique:
received: 11 07 2023
accepted: 31 01 2024
medline: 22 8 2024
pubmed: 22 8 2024
entrez: 22 8 2024
Statut: epublish

Résumé

Epilepsy, particularly in older people, is associated with significant changes in physical activities, social and occupational functions, and diet. It is associated with significant changes in physical activities, social and occupational functions, and diet. Valid and reliable instruments are needed to assess these changes. This study aimed to develop and validate a questionnaire to assess lifestyle in older people with epilepsy, named the Epilepsy Lifestyle Questionnaire (ELQ). This methodological study was conducted in 2022. The primary ELQ items were generated through reviewing the literature. Then, its face, content, construct, convergent, and discriminant validity, internal consistency, and test-retest stability were evaluated. Older patients aged ≥ 60 years were recruited from the Iranian Epilepsy Association to assess construct validity using confirmatory factor analysis (CFA). Data were analyzed using the SPSS (v. 26.0), AMOS (v. 24.0), and JASP software. The primary ELQ had 99 items with five subscales, namely health-oriented self-care, risk-averse behavior, emotional and psychosocial adaptation, epilepsy stigma, and intimacy and sexual behaviors. Sixty five items were deleted during psychometric evaluation. CFA showed the good fitting of the five-factor structure of the 34-item ELEQ (PCFI = 0.741, PNFI = 0.693, CMIN/DF = 0.073, IFI = 0.917, CFI = 0.916, AND GFI = 0.902). The values of internal consistency based on Cronbach's alpha and test-retest reliability based on intraclass correlation coefficient (ICC) of ELQ were 0.89 and 0.95, respectively. The ELQ is a valid and reliable self-report instrument. The results suggest that the ELQ is a useful clinical tool for assessing the lifestyle of patients with epilepsy.

Identifiants

pubmed: 39173054
doi: 10.1371/journal.pone.0298773
pii: PONE-D-23-21371
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0298773

Informations de copyright

Copyright: © 2024 Nadernejad et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Déclaration de conflit d'intérêts

The authors declare that they have no competing interests to disclose.

Références

Iran J Med Sci. 2022 May;47(3):236-247
pubmed: 35634526
Epilepsy Behav. 2017 Sep;74:27-32
pubmed: 28672217
Nutr Hosp. 2015 Aug 01;32(2):817-22
pubmed: 26268116
Epilepsia. 2002 May;43(5):539-49
pubmed: 12027917
Epilepsy Behav. 2020 Sep;110:107169
pubmed: 32504981
Epilepsy Behav. 2015 Apr;45:39-43
pubmed: 25801753
Epilepsy Behav. 2016 Feb;55:108-12
pubmed: 26773679
J Educ Health Promot. 2013 Feb 28;2:11
pubmed: 24083261
Epilepsy Behav. 2017 May;70(Pt A):198-203
pubmed: 28431368
BMC Public Health. 2016 Jan 28;16:89
pubmed: 26821644
Seizure. 2017 Mar;46:13-18
pubmed: 28214711
Seizure. 2013 Jun;22(5):384-9
pubmed: 23478508
Epilepsy Behav. 2016 Aug;61:231-236
pubmed: 27390026
BMC Public Health. 2014 Sep 24;14:995
pubmed: 25253039
Seizure. 2013 Nov;22(9):748-51
pubmed: 23796412
Epilepsy Behav. 2018 Jan;78:265-268
pubmed: 29126703
Soc Sci Med. 2003 Aug;57(4):577-93
pubmed: 12821008
Caspian J Intern Med. 2023 Winter;14(1):100-107
pubmed: 36741496
Health Qual Life Outcomes. 2020 Aug 12;18(1):277
pubmed: 32787957
Epilepsia. 2013 May;54(5):888-97
pubmed: 23506167
Lancet. 2012 Sep 29;380(9848):1128-30
pubmed: 23021270
Epilepsy Behav. 2019 Jul;96:141-149
pubmed: 31146178
J Clin Epidemiol. 2007 Jan;60(1):34-42
pubmed: 17161752
Epilepsy Behav. 2017 Dec;77:96-98
pubmed: 29033118
Patient Prefer Adherence. 2017 Jan 31;11:165-174
pubmed: 28203060
Pharmacoeconomics. 2018 Jun;36(6):645-661
pubmed: 29572719
Aust J Rural Health. 2020 Apr;28(2):168-179
pubmed: 32390206
Arq Neuropsiquiatr. 2007 Jun;65 Suppl 1:35-42
pubmed: 17581666
Nutr J. 2021 Jun 29;20(1):62
pubmed: 34187474
Epilepsia. 2016 Jan;57(1):6-12
pubmed: 26662920
Epilepsy Behav. 2015 Sep;50:172-83
pubmed: 26303037
Seizure. 2017 Oct;51:114-120
pubmed: 28843069
Epilepsy Behav. 2015 Mar;44:121-6
pubmed: 25678033
Epilepsia. 1998 Jan;39(1):81-8
pubmed: 9578017

Auteurs

Masomeh Nadernejad (M)

Department of Nursing, Babol University of Medical Sciences, Babol, Mazandaran, Iran.

Abbas Shamsalinia (A)

Department of Nursing, Babol University of Medical Sciences, Babol, Mazandaran, Iran.

Reza Ghadimi (R)

Department of Community Medicine, Babol University of Medical Sciences, Babol, Mazandaran, Iran.

Payam Saadat (P)

Department of Psychiatry, Babol University of Medical Sciences, Babol, Mazandaran, Iran.

Alijan Ahmadi Ahangar (A)

Department of Psychiatry, Babol University of Medical Sciences, Babol, Mazandaran, Iran.

Kourosh Gharagozli (K)

Department of Psychiatry, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Fatemeh Ghaffari (F)

Department of Nursing, Babol University of Medical Sciences, Babol, Mazandaran, Iran.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH